WhiteLab Genomics Secures €23.2 Million Series B Funding
Paris-based WhiteLab Genomics has announced it raised €23.2 million in Series B funding. This funding round, reported by EU-Startups, n24.com.tr, and konsulteer.com, is intended to accelerate the development of AI-driven genomic medicine. The information appears to stem from a company announcement.
3 articles from 3 outlets covered this story. The underlying claim is sourced from a press release.
What do all outlets agree on?
3 outlets covered “WhiteLab Genomics Secures €23.2 Million Series B Funding”. All of them report the following:
- WhiteLab Genomics raised Series B funding
- The amount raised is €23.2 million
- Funding is for AI-driven genomic medicine development
- WhiteLab Genomics is a Paris-based company
Which figures do outlets report differently?
1 figure in this story is reported with conflicting values:
Funding amount€23.2 million vs €23.2M
Which outlets covered this?
All 3 articles found on this story, grouped by the stance of the piece. Every link goes to the original publisher.
pragmatist3